We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Use Remote Regulatory Assessment Tools Beyond Pandemic
FDA to Use Remote Regulatory Assessment Tools Beyond Pandemic
The FDA announced Friday that remote regulatory assessments (RRA) have proven to be a valuable tool and the agency will continue to use them beyond the COVID-19 pandemic.
